The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
Open accessAbstract
The rising incidence of obesity and metabolic diseases such as diabetes mellitus and cardiovascular disease in adolescents and young adults is of grave concern. Recent studies favor a role of lifestyle factors over genetics in the perpetuation of inflammation, insulin resistance and oxidative stress, which are pathophysiologic processes common to the above diseases; furthermore, the importance of dietary factors in addition to calories and physical activity in these processes is being increasingly recognized. Advanced glycation end products (AGEs) belong to a category of dietary oxidants which have been implicated in the pathogenesis of inflammation, oxidative stress, insulin resistance, β-cell failure and endothelial dysfunction. This paper reviews the studies of AGEs with a focus on their role in cardiometabolic disease in children. A Medline search was performed using the key words ‘childhood obesity', ‘metabolic syndrome' and ‘advanced glycation end products'. Articles published in English between 1975 and 2015 and their references were reviewed. While most studies were performed in adults, a few studies also demonstrated a role of AGEs in obesity and associated cardiometabolic comorbidities in the younger population. Available evidence suggests an involvement of AGEs in the pathogenesis of adiposity and β-cell failure in children. Potential areas for further research to investigate underlying mechanisms are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Berenson, G. S., Wattigney, W. A., Tracy, R. E., Newman, W. P., Srinivasan, S. R., Webber, L. S., Dalferes, E. R., & Strong, J. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90726-f · Cited by 591
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes
Uribarri, J., Cai, W., Ramdas, M., Goodman, S., Pyzik, R., Chen, X., Zhu, L., Striker, G. E., & Vlassara, H. (2011) · Diabetes Care · doi:10.2337/dc11-0091 · Cited by 320
Self-citationTODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288
He, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
Lin, R.-Y., Reis, E. D., Dore, A. T., Lu, M., Ghodsi, N., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00008-4 · Cited by 109
Research works printed but not linked: 36
- 10.1152/ajpcell.00350.2007 · DOI
- 10.1042/CS20080494 · DOI · Paper page
- 10.1038/2012 · DOI · Paper page
- 10.1161/01.CIR.0000039325.03698.36 · DOI · Paper page
- 10.1167/iovs.04-1409 · DOI · Paper page
- 10.2741/E178 · DOI
- 10.1371/journal.pone.0066611 · DOI
- 10.1016/j.jada.2004.05.214 · DOI · Paper page
- 10.3275/7856 · DOI
- 10.1016/j.diabres.2006.09.016 · DOI
- 10.1016/j.metabol.2007.08.020 · DOI
- 10.1016/j.bbrc.2010.06.100 · DOI
- 10.1007/s00125-002-0912-8 · DOI
- 10.1053/jhep.2001.28788 · DOI · Paper page
- 10.1111/j.1440-1746.2007.04943.x · DOI · Paper page
- 10.2174/138161208784139701 · DOI
- 10.1074/jbc.M301088200 · DOI
- 10.2337/diabetes.54.8.2314 · DOI · Paper page
- 10.2337/diabetes.51.7.2082 · DOI · Paper page
- 10.1016/S0021-9150(03)00050-9 · DOI
- 10.1002/dmrr.283 · DOI · Paper page
- 10.1053/ajkd.2003.50084 · DOI
- 10.2337/diabetes.52.6.1441 · DOI
- 10.1073/pnas.1205847109 · DOI · Paper page
- 10.1371/journal.pone.0053056 · DOI
- 10.1016/j.cca.2010.03.033 · DOI
- 10.1159/000354831 · DOI
- 10.1210/jc.2009-0089 · DOI · Paper page
- 10.1210/jc.2014-3925 · DOI
- 10.2337/db11-0971 · DOI
- 10.1089/ars.2012.4525 · doi:10.1089/ars.2012.4525
- 10.2337/dc11-2302 · DOI
- 10.1089/ars.2010.3719 · DOI
- 10.3945/ajcn.2009.28737 · DOI
- 10.2337/dc06-0531 · DOI · Paper page
- 10.3109/10715762.2012.755262 · DOI
Cited by
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Metadata
- Authors
- Gupta, A., & Uribarri, J.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 291-300
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2302447233
- Cited by
- 4,006
- References
- 13
- FWCI
- 322.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children. https://app.cochat.ai/papers/10.1159/000444053
- The paper
- Gupta, A., & Uribarri, J. (2016). Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children. Hormone Research in Paediatrics. https://doi.org/10.1159/000444053
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
